Management will host a public webcast at 1:30 p.m. Pacific Time to discuss the results with analysts and investors. Interested parties can access the audio stream and supplemental materials through the company’s investor relations portal. The recording will remain available for replay for a minimum of 45 days following the broadcast.
In section Releases
10x Genomics Sets November 5 Date for Third Quarter Results
Pleasanton-based biotechnology firm 10x Genomics will disclose its financial performance for the third quarter of 2026 on November 5. The company intends to release its earnings statement after the close of the market, followed by a live conference call to outline recent business developments and forward-looking projections.
10x Genomics continues to focus on single-cell and spatial biology, providing hardware and software tools to researchers in oncology, immunology, and neuroscience. The firm maintains its standard disclosure practices, utilizing its official website and SEC filings to communicate material information to shareholders.
Comments (0)
No comments yet. Be the first!